Hofseth BioCare ASA: Extraordinary General Meeting completed

Company Overview - Hofseth BioCare ASA (HBC) is a Norwegian consumer and pet health company focused on sustainability and optimal utilization of natural resources [1] - The company upcycles by converting side streams of the salmon industry into health-improving ingredients for humans and pets [1] Product Offerings - HBC's key products include ProGo®, a mix of bioactive peptides and collagen, OmeGo®, a whole salmon oil, and CalGo® / NT-II® salmon bone powder [2] - ProGo® enhances iron metabolism, leading to increased energy and vitality [3] - OmeGo® provides immune health benefits and aids recovery from viral infections [3] - CalGo® supports bone and joint health, promoting healthy aging and active lifestyles [3] Scientific Research and Development - HBC emphasizes scientific evidence, resulting in academic partnerships and unique health benefit discoveries [3] - The company has secured patents for its findings and has identified potential therapeutics, leading to the establishment of HBC Immunology (HBCI) [3] - HBCI has raised external finance for its lead program targeting prostate cancer and ovarian cancer, along with a molecule aimed at asthma treatment [3] Corporate Structure and Location - HBC is headquartered in Ålesund, Norway, with branches in Oslo, London, Zürich, and Palo Alto [4] - The company is listed on the Oslo Stock Exchange under the ticker "HBC" [4]